Bronchial responsiveness to methacholine and adenosine 5′- monophosphate in preschool children with bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 41, Issue 6, 2006, Pages 538-543

  Kim, Do Kyun ^a   Choi, Sun Hee ^a   Yu, Jinho ^b   Yoo, Young ^c   Kim, Beyong Il ^a   Koh, Young Yull ^a  

^a Seoul National University Hospital   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Adenosine 5 monophosphate; Asthma; Bronchial hyperresponsiveness; Bronchopulmonary dysplasia; Methacholine

Indexed keywords

ADENOSINE PHOSPHATE; IMMUNOGLOBULIN E; METHACHOLINE; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHUS; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; HUMAN; LUNG DYSPLASIA; MALE; OXYGEN SATURATION; OXYGEN THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; WHEEZING;

ADENOSINE MONOPHOSPHATE; ASTHMA; BLOOD CELL COUNT; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOPULMONARY DYSPLASIA; CHILD; CHILD, PRESCHOOL; EOSINOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFANT, NEWBORN; MALE; METHACHOLINE CHLORIDE; OXIMETRY; OXYGEN; RESPIRATORY SOUNDS;

EID: 33744502354     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20402     Document Type: Article

References (30)

1. Eber E, Zach MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 2001;56: 317-323.
2. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am 1994;41:277-315.
3. Smith L, McFadden ER Jr. Bronchial hyperreactivity revisited. Ann Allergy Asthma Immunol 1995;74:454-470.
4. Allen J, Zwerdling R, Ehrenkranz R, Gaultier C, Geggel R, Greenough A, Kleinman R, Klijanowicz A, Martinez F, Ozdemir A, Panitch HB, Nickerson B, Stein MT, Tomezsko J, Van Der Anker J, American Thoracic Society. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003;168:356-396.
5. Smyth JA, Tabachnik E, Duncan WJ, Reilly BJ, Levison H. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics 1981;68: 336-340.
6. Northway WH Jr, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, Brown BW Jr. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323:1793-1799.
7. Pelkonen AS, Hakulinen AL, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med 1997;156:1178-1184.
8. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo JL. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J [Suppl] 1993;16: 53-83.
9. de Meer G, Marks GB, Postma DS. Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology? Clin Exp Allergy 2004;34:9-16.
10. Avital A, Picard E, Uwyyed K, Springer C. Comparison of adenosine 5′-monophosphate and methacholine for the differentiation of asthma from chronic airway diseases with the use of the auscultative method in very young children. J Pediatr 1995;127:438-440.
11. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995; 50:511-516.
12. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
13. Springer C, Godfrey S, Picard E, Uwyyed K, Rotschild M, Hananya S, Noviski N, Avital A. Efficacy and safety of methacholine bronchial challenge performed by auscultation in young asthmatic children. Am J Respir Crit Care Med 2000;162: 857-860.
14. Avital A, Uwyyed K, Berkman N, Godfrey S, Bar-Yishay E, Springer C. Exhaled nitric oxide and asthma in young children. Pediatr Pulmonol 2001;32:308-313.
15. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final natality statistics: 1996. Mon Vital Stat Rep [Suppl] 1998;46:1-99.
16. Halvorsen T, Skadberg BT, Eide GE, Roksund OD, Carlsen KH, Bakke P. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr Scand 2004;93: 1294-1300.
17. Robin B, Kim YJ, Huth J, Klocksieben J, Torres M, Tepper RS, Castile RG, Solway J, Hershenson MB, Goldstein-Filbrun A. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol 2004;37:236-242.
18. Yong SC, Smith CM, Wach R, Kurian M, Primhak RA. Methacholine challenge in preschool children: methacholine-induced wheeze versus transcutaneous oximetry. Eur Respir J 1999;14:1175-1178.
19. Mochizuki H, Ohki Y, Nako Y, Morikawa A. Transcutaneous oxygen tension measurements during methacholine challenge of prematurity in infants with chronic lung disease. Pediatr Pulmonol 1998;25:338-342.
20. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113: 131-139.
21. Woolcock AJ, Anderson SD, Peat JK, Du Toit JI, Zhang YG, Smith CM, Salome CM. Characteristics of bronchial hyperresponsiveness in chronic obstructive pulmonary disease and in asthma. Am Rev Respir Dis 1991;143:1438-1443.
22. Chan KN, Elliman A, Bryan E, Silverman M. Clinical significance of airway responsiveness in children of low birth-weight. Pediatr Pulmonol 1989;7:251-258.
23. Hislop AA, Haworth SG. Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. Am Rev Respir Dis 1989;140:1717-1726.
24. Baraldi E, Bonetto G, Zacchello F, Filippone M. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med 2005;171:68-72.
25. 20 methacholine. Am J Respir Crit Care Med 2001;163:1546-1550.
26. Spicuzza L, Polosa R. The role of adenosine as a novel bronchoprovocant in asthma. Curr Opin Allergy Clin Immunol 2003;3:65-69.
27. 1. Am J Respir Crit Care Med 2002;165:327-331.
28. van den Berge M, Polosa R, Kerstjens HA, Postma DS. The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2004;114: 737-746.
29. Kennedy JD. Lung function outcome in children of premature birth. J Paediatr Child Health 1999;35:516-521.
30. Riedel F. Long term effects of artificial ventilation in neonates. Acta Paediatr Scand 1987;76:24-29.